No. of resources: 2
Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19

Region : Global Commitment

Topics : COVID-19

Year :

Source :

Lilly's COVID-19 Science Leads to a Second FDA Emergency Use Authorization

Region : Global Commitment

Topics : COVID-19

Year :

Source :